Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12605000468628
ACTRN12605000468628
Completed
Phase 1

A pharmacokinetic study to assess the comparative bioavailability of 17-B-estradiol from Metered-Dose Transdermal Sprays (MDTS) and Estraderm 50 patches as hormone replacement therapy in postmenopausal women.

FemPharm Pty Ltd and/or Acrux DDS Pty Ltd0 sites12 target enrollmentSeptember 23, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHormone replacement therapy in postmenopausal womenReproductive Health and Childbirth - Menstruation and menopause

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hormone replacement therapy in postmenopausal women
Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
Enrollment
12
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 23, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • •Healthy post\-menopausal women

Exclusion Criteria

  • •No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A research study of how fast-acting insulin aspart works in the body of children, young people and grown-ups with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 20.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2017-002014-31-DEovo Nordisk A/S43
Not yet recruiting
Phase 1
Effect of Jianpi Qushi Recipe on hyperuricemia patients and the serum levels of inflammatory cytokineshyperuricemia patients
ITMCTR2200005783Department of Immunity,the Tianjin FirstHospital,Tianjin,
Active, not recruiting
Not Applicable
Raltegravir/Lamivudine Drug Interaction Study
EUCTR2015-002237-22-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.24
Not yet recruiting
Phase 3
A clinical trial to study the effects of kaphaketu rasa with two different anupama in patients with peenasa roga.Health Condition 1: J310- Chronic rhinitis
CTRI/2022/09/045219Government Ayurvedic College
Completed
Not Applicable
A Phase 1 Study to Compare the Pharmacokinetics of CAL-101 Capsules to Tablets in Healthy Male Subjects.Blooddiseaseleukemia/lymophoma10047954
NL-OMON35094Calistoga Pharmaceuticals Inc.15